Trial Profile
A multi-center prospective cohort study to determine clinical features, morphology and aetiology of dupilumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Nov 2022
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis; Erythema
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2022 Results published in the Journal of the European Academy of Dermatology and Venereology
- 31 Oct 2022 New trial record